Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1745studies shown
Showing 1,297-1,308 of 1,745
Drug study icon
CompletedISRCTN68824876

Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Imperial College London
Condition
Schizophrenia
Other study type icon
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This observational study is following people with Clinical High Risk, Psychosis, Remission, or Conversion to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United Kingdom
SchizophreniaOtherFrom 12 Years to 30 Years
Countries
United States, Australia, Canada, ...
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT02473289

Sirukumab for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing sirukumab for depression.

In United Kingdom
DepressionDrugFrom 21 Years to 64 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02498392

Safety study of JNJ-42165279 in depression

This study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-42165279 for depression.

In United Kingdom
Depression, AnxietyDrugFrom 18 Years to 64 Years
Countries
United States, United Kingdom, Moldova, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Anxiety
Drug study icon
CompletedNCT06237426

Methylone for PTSD

This study is completed in the United States, in the United Kingdom, and in Ireland. It is testing methylone for PTSD.

In United Kingdom
PTSDDrugFrom 18 Years to 71 Years
Countries
United States, United Kingdom, Ireland
Sponsor
Transcend Therapeutics
Condition
PTSD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.